Proteome Differences in Smooth Muscle Cells from Diabetic and Non-Diabetic Abdominal Aortic Aneurysm Patients Reveal Metformin-Induced Mechanisms
Medical Sciences · 2025
DOI: 10.3390/medsci13030184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Tara A R van Merrienboer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Metformin, Aortic Aneurysm, Abdominal, Myocytes, Smooth Muscle, Proteome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation, DHF Aneurysm-NL consortium.
Abstract (Originalsprache)
Aims
Surgery remains the only definitive treatment option for abdominal aortic aneurysms (AAA), as no conclusive evidence supports drug effectiveness in preventing AAA growth. Although type 2 diabetes (T2D) is an important cardiovascular risk factor, patients with T2D show reduced AAA presence and growth, associated with metformin use. We aimed to investigate the potential benefits of metformin on AAA using proteomics and in vitro experiments.
Methods
Proteomics analysis using tandem mass spectrometry was performed on aortic smooth muscle cells (SMCs) from non-pathological controls (C-SMC, n = 8), non-diabetic (ND, n = 19) and diabetic (D, n = 5) AAA patients. Key findings were subsequently validated in aortic tissue using mass spectrometry-based proteomics. SMCs were cultured with/without metformin and analyzed.
Results
Comparison of the proteome of SMCs from ND-AAA patients with controls revealed a reduction in proteins associated with metabolic processes and mitochondrial function. Cytoskeletal and extracellular matrix (ECM) proteins were elevated in ND-AAA-SMCs versus C-SMCs, with a similar cluster of mechanosensitive proteins being increased in ND-AAA-SMCs versus D-AAA-SMCs. D-AAA-SMCs showed an improved metabolic and antioxidant profile, enriched in pentose phosphate pathway proteins responsible for NAD(P)H generation (G6PD, PGD) and NAD(P)H-dependent antioxidants (NQO1, CBR1, AKR1C1, AKR1B1, GSTM1), all regulated by NRF2, an antioxidant transcription factor. Over half of the proteins identified in the protein–protein interaction network, constructed from proteins with higher expression in D-AAA SMCs versus ND-AAA SMCs, were verified in D-AAA aortic tissue. In vitro, metformin causes a shift from aerobic to anaerobic metabolism, increased AMPK activation and elevated mitochondrial biogenesis, indicated by increased PGC-1α expression. Metformin increased the gene expression of PGD, CBR1 and the protein expression of NQO1, with enhanced translocation of pNRF2 to the nucleus, due to reduced KEAP1 as negative regulator of NRF2. Consequently, metformin enhanced the gene expression of well-known antioxidant regulators SOD2 and CAT.
Conclusions
This study identified significant differences in the proteome of SMCs derived from controls, ND-AAA and D-AAA patients. It highlights distinct pathways in relation to mechanosensing, metabolism and redox balance as therapeutic targets of metformin that may underlie its inhibition of AAA progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Department of Medical Biochemistry, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam Cardiovascular Sciences, Atherosclerosis and Aortic Diseases, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Department of Physiology, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- OncoProteomics Laboratory, Medical Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Van der Boechorststraat 6, 1081 BT Amsterdam, The Netherlands.
- Proteomics Core Resource, Amsterdam UMC location Vrije Universiteit Amsterdam, Van der Boechorststraat 6, 1081 BT Amsterdam, The Netherlands.
ORCID-Profile: Tara A R van Merrienboer, Ron Balm
Förderung
- Dutch Heart Foundation
- DHF Aneurysm-NL consortium
Zitieren
APA
van Merrienboer, T. A. R., Rombouts, K. B., van Wijk, A. C. W. A., Knol, J. C., Pham, T. V., Piersma, S. R., Jimenez, C. R., Balm, R., Yeung, K. K., & de Waard, V. (2025). Proteome Differences in Smooth Muscle Cells from Diabetic and Non-Diabetic Abdominal Aortic Aneurysm Patients Reveal Metformin-Induced Mechanisms. Medical Sciences. https://doi.org/10.3390/medsci13030184
Vancouver
van Merrienboer TAR, Rombouts KB, van Wijk ACWA, Knol JC, Pham TV, Piersma SR, et al. Proteome Differences in Smooth Muscle Cells from Diabetic and Non-Diabetic Abdominal Aortic Aneurysm Patients Reveal Metformin-Induced Mechanisms. Medical Sciences. 2025. doi:10.3390/medsci13030184
BibTeX
@article{vanMerrienboer2025,
author = {van Merrienboer, Tara A R and Rombouts, Karlijn B and van Wijk, Albert C W A and Knol, Jaco C and Pham, Thang V and Piersma, Sander R and Jimenez, Connie R and Balm, Ron and Yeung, Kak K and de Waard, Vivian},
title = {Proteome Differences in Smooth Muscle Cells from Diabetic and Non-Diabetic Abdominal Aortic Aneurysm Patients Reveal Metformin-Induced Mechanisms},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030184}
}
EUVIMED